Circulars Circular No. 2020-033-B
FDA
Food and Drug Administration
Administrative issuances
25 issuances
Circulars Circular No. 2023-006
Updated Guidelines on the Filing and Submission of Applications for the Licensing and Registration of Household/Urban Hazardous Substances (HUHS) Establishments and Products, Respectively, through the FDA E-Portal V.2 System
Circulars Circular No. 2021-002-C
Guidelines on the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No. 2020-001-A entitled "Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No.2018-0002 "Guidelines Governing the Issuance of an Authorization for a Medical Device Based on the ASEAN Harmonized Technical Requirements"
- Circular No. 2023-005
Guidelines on the Implementation of the FDA Student Internship Program
Circulars Circular No. 2023-004
Guidelines on Regulatory Reliance on the Conduct of Clinical Trials
Circulars Circular No. 2023- 004
Guidelines on Regulatory Reliance on the Conduct of Clinical Trials
Circulars Circular No. 2022-004-A
Amendment to FDA Circular No. 2022-004 entitled "Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals" to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies
- Circular No. 2023-003
Guidelines on the Filing and Submission of Acceptable Variations on Protocols and Non-Standard Protocols for the Review and Pre-Approval by the Food and Drug Administration Prior to the Conduct of Bio-efficacy Test Studies of Household Pesticides for the Purposes of Securing a Certificate of Product Registration
- FDA Circular No. 2023-002
Guidelines on the Conduct of Regulatory Inspections for Radiation Facilities
- FDA Circular No. 2023-001
Updated Guidelines on Product Information File (PIF) for Cosmetic Products Repealing FDA Circular No. 2018-001 "Reiterating the Mandatory Implementation of Article 8 of the ASEAN Cosmetic Directive Product Information"
- Circular No. 2022-012
Guidelines on the Microbiological Requirements and Assessment of Certain Prepackaged Processed Food Products Repealing FDA Circular No. 2013-010 entitled "Revised Guidelines for the Assessment of Microbiological Quality ofProcessed Foods
- Circular No. 2022-010